Latest Venous thrombosis Stories

Linda Flinterman of Leiden University, the Netherlands and colleagues report in this week's PLoS Medicine on the long-term mortality rate for individuals who have experienced a first venous thrombosis or pulmonary embolism. They describe an ongoing elevated risk of death for individuals who had experienced a venous thrombosis or pulmonary embolism as compared to controls, for up to eight years after the event. The authors say: "To our knowledge, this has been the first study to calculate...

TOKYO and SAN DIEGO, Dec. 12, 2011 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the results of a pooled analysis showing that edoxaban, a direct oral once-daily Factor Xa inhibitor, significantly reduced the risk of developing venous thromboembolism (VTE) following total knee or hip arthroplasty, when compared to enoxaparin. Patients receiving edoxaban had a lower incidence of a composite of deep vein thrombosis (DVT) and pulmonary...

DENVER, Dec. 8, 2011 /PRNewswire-USNewswire/ -- Deep vein thrombosis (DVT) is a blood clot in the deep veins in the legs. These clots can break loose and travel to the lungs, causing a potentially fatal pulmonary embolism (PE). Even when they don't, they can cause permanent damage to the leg veins that results in long-term pain, swelling, and disability of the leg. (Logo: <font size="2" face="Arial">http://photos.prnewswire.com/prnh/20110303/DC58830LOGO</font>) Deep...

RICHMOND, Va., Nov. 30, 2011 /PRNewswire/ -- Health Diagnostic Laboratory, Inc. (HDL, Inc.) announced today that medical advisory board member Michael F. Richman M.D., F.A.C.S., founder of the Center for Cholesterol Management and The Elite Laser Vein Center in Los Angeles, has initiated a study that will analyze the relevance of MTHFR polymorphisms in venous disease with or without concomitant thrombosis. It has been reported that a mutation in the gene encoding...

(Ivanhoe Newswire) – Drospirenone-containing oral birth control pills are linked to a significantly higher risk of blood clots, both deep vein thrombosis and pulmonary embolism, according to this study. All oral contraceptives are associated with a higher risk of blood clots, but there is conflicting information about the risk of adverse events with drospirenone. Many previous studies have evaluated risks of second- and third-generation contraceptives, which both contain derivatives of...

The use of drospirenone-containing oral birth control pills is linked to a significantly higher risk of blood clots, both deep vein thrombosis and pulmonary embolism, according to an article in the Canadian Medical Association Journal. All oral contraceptives are associated with a higher risk of blood clots, but there is conflicting information about the risk of adverse events with drospirenone. Many previous studies have evaluated risks of second- and third-generation contraceptives,...

LEXINGTON, Mass., Oct. 20, 2011 /PRNewswire/ -- InaVein, LLC today announced publication of a peer-reviewed paper that examines use of the TRIVEX transilluminated powered phlebectomy (TIPP) System for removal of varicose veins in a clinical office rather than a hospital setting. The paper, Transilluminated Powered Phlebectomy in an Office Setting: Procedural Considerations and Clinical Outcomes was authored by Gregory A. Spitz, M.D., FACS (AmeriVein Systems, Aurora, Illinois) and published...

Patients with inflammatory bowel disease (IBD) undergoing surgery may be more likely to develop deep vein thrombosis (DVT; blood clot in a deep vein in the thigh or leg) or pulmonary embolism (PE; blood clot in blood vessels in the lungs) following surgical procedures, according to a study published Online First by Archives of Surgery, one of the JAMA/Archives journals. "An increased risk of DVT and PE in patients with IBD has been evident for the past 75 years," the authors write as...

Patients with clinically diagnosed superficial vein thrombosis (SVT), a blood clot in the veins just beneath the skin that commonly resolves on its own without treatment, are four to six times more likely to develop venous thromboembolism (VTE), a dangerous, often life-threatening condition, according to study results published today in Blood, the Journal of the American Society of Hematology (ASH).Recent studies have shown that patients diagnosed with SVT using ultrasound to confirm the...

A new risk prediction tool can identify patients at high risk of serious blood clots who might need preventative treatment, according to a study published on bmj.com.The tool, which can be found at www.qthrombosis.org, is based on simple variables which the patient is likely to know and could be easily integrated into GP computer systems to risk assess patients prior to hospital admission, long haul flights, or starting medications that carry an increased clotting risk.The condition, known as...